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Lichen planus (LP) is an inflammatory dermatosis of autoimmune origin, which affects 
the skin and mucosae. Although the aetiology of LP remains uncertain, certain viruses 
(eg, hepatitis B and C), contact with diverse substances (eg, mercury and copper) and 
neoplasias have been linked to the condition. 
 
A 44-year-old woman presented at our department in 2003 with multiple pruritic 
papules spread over her trunk and extremities, and was diagnosed with LP. No mucosal 
lesions were observed. The diagnosis was histologically confirmed. Viral infection, 
contact with triggering substances, and use of medications were all ruled out. Treatment 
with sulfasalazine was begun and 5 months later, the lesions had disappeared. After a 
lesion-free period of 2 months, the patient was diagnosed with infiltrating ductal 
carcinoma in the left breast. She underwent a tumorectomy and was treated with 
chemotherapy and external radiotherapy of up to 60 Gy in the left breast, completing 
treatment after 2 months. Five months after terminating radiotherapy, the patient 
returned to our department, reporting a 4-month evolution of shiny violaceous papules 
clustered in the inframammary crease. The cutaneous lesions coincided exactly with the 
irradiated area (Fig. 1). A biopsy was performed and histopathological findings were 
consistent with LP. After 1 month of treatment with clobetasol propionate 0.05%, the 
lesions disappeared. 
 
The isomorphic Kóbner phenomenon appears in a variety of dermatoses, including LP. 
However, the appearance of LP confined to an irradiated site is extremely rare. Only 
two cases have been published by Kim and Krivda,1 and by Shurman et al.2 However, in 
our case, the radiotherapy induced the reappearance of the LP lesions in a patient who 
had previously presented with the disease and who had been free of lesions up to that 
moment. In our case, as in Kim and Krivda’s,1 there was a 1-month latency period from 
the moment radiotherapy was completed to the appearance of LP. 
   
 
T lymphocytes have been found to play a primordial role in the pathogenesis of LP. 
Furthermore, it is possible that the increase of adhesion molecules such as endothelial 
leukocyte adhesion molecule-1, intercellular adhesion molecule (ICAM)-1 and vascular 
cell adhesion molecule-1 via endothelial cells may also play an important role.3 
 
The mechanism by which LP develops after radiotherapy is unknown. Radiotherapy is 
known to have immunomodulatory properties. Exposure to low doses of radiation 
modulates the function of both macrophages and T lymphocytes, and induces a selective 
enhancement of CD8+ T-cell responses.4 It has been shown that radiation increases the 
expression of proinflammatory molecules such as major histocompatibility complex 
(HMC), adhesion molecules (ICAM-1 and E-selectin in the endothelium) and cytokines, 
although the mechanism by which they are produced remains somewhat unclear. The 
immunomodulation process has been shown to last up to 6 months after completion of 
radiotherapy. The ICAM-1 levels probably rise markedly during treatment and 
gradually fall until they reach preradiotherapeutic levels 6 months after the end of 
treatment. This would not occur with E-selectin, the levels of which would increase 
during treatment, then decrease upon completion of radiotherapy, but would not return 
to baseline levels.5 Therefore, adhesion molecules may play an important role in the 
transendothelial migration of leucocytes and consequently in the inflammatory cell 
composition of the tissue. Radiation therefore most likely reproduces the inflammatory 
reaction involved in LP. Nevertheless, some studies have shown that low doses of 
fractionated radiotherapy may have anti-inflammatory effects and diminish the 
expression of adhesion molecules such as E-selectin.6 Interestingly, ionizing radiation 
was used in the past to treat certain inflammatory dermatoses. 
 
We present a new case of LP induced by radiotherapy and propose that external 
radiotherapy may be another factor to consider as a cause of köbnerization in various 
dermatoses. 
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Figure 1. Violaceous polygonal papules clustered in the inframammary crease, the site 
treated by radiotherapy. 
